key: cord-0040910-t0fqhizy
authors: Farsang, A.; Ros, C.; Renström, Lena H. M.; Baule, Claudia; Soós, T.; Belák, S.
title: Molecular epizootiology of infectious bronchitis virus in Sweden indicating the involvement of a vaccine strain
date: 2010-06-17
journal: Avian Pathol
DOI: 10.1080/03079450220136530
sha: fe74b9ea8f876ad0637e906998c5581bcff3c39b
doc_id: 40910
cord_uid: t0fqhizy

To improve the detection and molecular identification of infectious bronchitis virus (avian coronavirus), two reverse transcriptase-polymerase chain reaction (PCR) assays were developed. As ‘diagnostic PCR’, a set of consensus nested primers was selected from highly conserved stretches of the nucleocapsid (N) gene. As ‘phylogeny’ PCR, a fragment of the spike protein gene (S1) was amplified and the PCR products were directly sequenced. To study the phylogenetic relationships of the viruses from various outbreaks, studies of molecular epizootiology were performed in Sweden, a Nordic region, where the occurrence of natural cases of the disease is relatively low and the occasional use of live vaccine(s) is well recorded and monitored. The disease appeared in the region in 1994, associated with production problems among layers of various ages. During outbreaks in 1995 and 1997, both layers and broilers were affected. To reduce losses, a live attenuated vaccine has been applied since 1997. By examining 12 cases between 1994 and 1998, molecular epizootiology revealed that, before 1997, the viruses had gene sequences very similar to strains of the Massachusetts serotype. However, comparative sequence analysis of the S1 gene revealed that the identity was not 100% to any of the strains of this serotype that we analysed. A virus related to the Dutch-type strain, D274, was also identified on one farm. Surprisingly, from 1997, the year that vaccination commenced with a live Massachusetts serotype vaccine, the majority of viruses detected had S1 sequences identical to the live Massachusetts vaccine strain. This genetic relation to the vaccine virus was also confirmed by N gene sequence analysis. The studies of molecular epizootiology reveal a strong probability that the vaccination had lead to the spread of the vaccine virus, causing various disease manifestations and a confusing epizootiological situation in the poultry population.

Infectious bronchitis virus (IBV) is a highly infectious and contagious pathogen of chickens worldwide. The genome of IBV, a member of the family Coronaviridae , contains a single-stranded, positivesense RNA of 27.6 kb (Boursnell et al., 1987) . The virion is an enveloped pleomorphic particle approximately 80 to 100 nm in diameter and has three major virus-encoded structural proteins, which include the spike (S) glycoprotein, the membrane (M) protein, and the nucleocapsid (N) protein. The spikes of IBV are formed by post-translational cleavage of two separate polypeptide components designated S1 and S2 (Cavanagh, 1983a,b) . The molecular identification of IBV is based mainly on analysis of the S1 protein gene (Lin et al., 1991; Handberg et al., 1999; Kingsham et al., 2000; de Wit, 2000; Cavanagh, 2001a,b; Li & Yang, 2001) . The N protein is closely associated with the RNA genome (Lai & Cavanagh, 1997) .

IBV replicates in the respiratory and urogenital tract, causing various disease manifestations, and affecting both production and egg quality (King & Cavanagh, 1991) . Since the first description by Schalk & Hawn (1931) in the US, many strains, which vary widely in virulence, have been identified (Fabricant, 1998) . Serological studies revealed that IBV could be divided into more than 20 serotypes.

The control of infectious bronchitis (IB) is based on various policies of epizootiology, including the use of live attenuated vaccines. The live vaccines prepared from Massachusetts serotype strains provide good immunity against the homologous serotype. Thus, such vaccines have been used worldwide for decades (Sharma, 1999) . However, the disadvantage of the live vaccine strains is that they are spreading in the field (Meulemans et al., 2001) . This creates an epizootiological problem, since the exact discrimination between live Massachusetts vaccine strains and Massachusetts wild strains is very difficult. A further problem is that immune response induced by a Massachusetts-type vaccine is often not sufficiently effective against new serotypes , which emerge due to changes in the IBV genome, including deletions, insertions, point mutations and, in some cases, recombinations (King, 1988; Wang et al., 1994; Jia et al., 1995; Lee & Jackwood, 2001 ). In such a confusing epizootiological situation, the rapid and accurate identification of newly emerging IBV variants is very important (King, 1988; Kwon et al., 1993; Cavanagh et al., 1999; Lee & Jackwood, 2001) .

Considering these high risk factors, it is important to study the capacity of vaccine viruses to spread and initiate disease. Furthermore, reliable and practical methods are required to discriminate between wild viruses and spreading vaccine strains. To investigate this scenario, Sweden was chosen as the scene of our study. This is a region where the occurrence of natural cases of IB is relatively low and the occasional use of vaccine(s) is well recorded and monitored. In this country, the last natural outbreak of IB (before the present cases) occurred in the 1970s. No vaccination was practised before 1997.

Concerning natural cases of the present study, the first outbreak was recorded in February 1994, affecting layers, followed by second case in 1995 among layers and broilers, respectively. Since the losses became increasingly frequent, in spring 1997 the authorities permitted immunization against IBV using a live attenuated vaccine. After vaccination, production problems were observed in a number of flocks, and it could not be excluded that the vaccine virus was spreading and maintaining a very complicated epizootiological situation. These problems emphasized the need to: (i) develop a highly sensitive and specific novel method to detect and identify IBV; and (ii) to determine the genetic relationship of the viruses in the field cases, with special regard to possible spread of the vaccine strain in poultry populations.

To meet these purposes, two reverse transcriptase-polymerase chain reaction (RT-PCR) assays were developed. To detect all possible variants with appropriate sensitivity, a nested 'diagnostic' PCR was constructed, targeting the most conservative regions of the N gene of IBV. To perform further strain identification and phylogeny, a 'phylogeny' PCR assay was applied to amplify the most variable region of the S1 gene. The nucleotide sequences of the PCR products were determined and comparative analysis was performed to estimate the phylogenetic relationship of the viruses, with specific regard to a supposed spread and possible damage caused by the vaccine virus in the flocks.

Before 1997 no IB vaccines were applied in Sweden. Twelve cases, occurring on different farms between 1994 and 1998 ( Table 1) , were previously diagnosed as IB, using a blocking enzyme-linked immunosorbent assay (ELISA) test (L.H.M. Renström, unpublished results). The first outbreaks affected layers, causing production problems in 1994. The outbreaks in 1995 and 1997 happened among layers and broilers, respectively. The manifestations were drops in egg production, poor egg quality, coughing and sneezing. Virus isolation was not performed; the specimens from these 12 cases (Table 1) Sweden. b In the case of these samples, the 'phylogeny' PCR (S1) was unsuccessful. c Due to ethical reasons, the name of the vaccine strain is not given here.

Specimens of tracheas and intestines were analysed. The samples were maintained separately.

The organ specimens from the infected animals were homogenized, 1 g tissue in 8 ml phosphate-buffered saline without calcium and magnesium (PBS). Total RNA was prepared by mixing 166 ml homogenized organ, 245 ml PBS, 83 ml 6 ´proteinase K buffer ( 0.01 M Tris (pH 7.8), 0.005 M ethylenediamine tetraacetic acid and 0.5% sodium dodecyl sulfate) and 5 ml proteinase K (14 mg/ml; Boehringer Mannheim, Germany). The mixture was incubated for 1 h at 55°C. The RNA was extracted by Trizol™ LS (Gibco) (Verhofstede et al., 1996) . The precipitated RNA was pelleted at 14 000 ´g for 30 min, washed once with 400 ml of 70% ethanol, dried and dissolved in 50 ml freshly prepared diethyl pyrocarbonate-treated water (DEPC) (Fluka Chemi AG, Buchs, Switzerland), and used immediately or stored at -70°C (Vilcek et al., 1994) .

Specimens of cDNA were synthesized in 25 ml reaction mixtures containing 5 ml specimen RNA, 5 ml DEPC-treated water and 1 ml random hexamers (0.02 U; Pharmacia Biotech, Uppsala, Sweden). RNA was denatured at 65°C for 5 min. Subsequently, the tubes were placed on ice, and 17 ml premix containing 1 ml RNAguard (24 U; Pharmacia), 2.5 ml each dNTP ( 2 mM; Pharmacia), 5 ml of 5 ´firststrand reaction buffer (Gibco BRL; Bethesda, MD, USA), and 1 ml Moloney murine leukaemia virus reverse transcriptase ( 200 U; Gibco BRL) was added. The reaction mixtures were incubated at 37°C for 90 min followed by inactivation of the enzyme at 98°C for 5 min.

For diagnostic purposes, two primer pairs (N784 to N1145 and N791 to N1129, respectively) were designed to detect IBV in the animals. The primer sequences are situated in the nucleocapsid (N) gene. To ensure a very wide detection range, the primers were selected on the basis of a large collection of IBV sequences; all of the 14 nucleocapsid sequences available in GenBank (Table 2) . Sequences, orientation and nucleocapsid positions of the primers are presented in Table 3 . The amplification reaction was carried out in 50 ml mixtures containing 0.2 mM each deoxynucleotide, 10 pmol each primer (the external primers N984 and N1145), 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 2.5 mM MgCl 2 , 1 U Taq DNA polymerase (Perkin Elmer-Cetus, Norwalk, CO, USA), and 3 ml cDNA. Two droplets of mineral oil (Sigma) were added to prevent evaporation. Amplification was performed with a thermal profile of 94°C for 45 sec, 60°C for 1 min and 72°C for 2 min. This cycle profile was repeated 35 times with a final extension at 72°C for 7 min. After the first run of amplification, 1 ml amounts of the PCR products were added to a fresh reaction tube containing identical reagents and the internal primers (N794 and N1129). The thermal profile of the second run of amplification was 94°C for 45 sec, 53°C for 1 min and 72°C for 1 min.

For visualization, 5 ml amounts of the PCR products were electrophoresed in 2% agarose gels. After electrophoresis, the gels were stained in ethidium bromide and viewed under ultraviolet light.

As judged by comparative studies of 37 sequences available in GenBank (Table 4) , the first half of the S1 gene allows a very high phylogenetic resolution. Accordingly, two primers were selected to amplify a region (840 bases) from the first half of the S1 gene. The thermal profile of the 'phylogeny' PCR was 94°C for 45 sec, 55°C for 1 min and 72°C for 1 min. The PCR products were sequenced by an ABI PRISM device with dye terminators (Applied Biosystems Inc., Foster City, CA, USA). The nucleotide and deduced amino acid sequences were aligned with the aid of the multiple programs DNASTAR (DNASTAR Inc., Madison, WI, USA), using the Clustal method (Verhofstede et al., 1996) . In the alignment, all the sequences available from the S1 gene were included.

The nucleotide sequence data reported in this paper have been submitted to the GenBank sequence database and have been assigned the accession numbers AF420320 to AF420330.

Genetic diversity and detection of IBV 231 

Using primer pairs N784 to N1145 and N791 to N1129 from the highly conservative N gene in nested RT-PCR, IBV was detected in all the 12 tested clinical samples. By testing reference viruses Netherlands /D1466/78, Netherlands/H120/55, UK/ 7/91 and UK/918/68 (kindly provided by Dr D. Cavanagh), the primers gave positive reactions with all of these strains. In each of these cases, PCR products were detected in the first run of amplification. However, to provide the possible highest sensitivity of virus detection, we always used nested PCR throughout these studies.

Except for the viruses SE/242/95 and SE/340/94, the S1 gene RT-PCR system detected the virus in all specimens collected between 1994 and 1998. The PCR products were suitable to determine the phylogenetic relations of the detected viruses, in comparison with sequences available in GenBank. Figure 1 shows the dendrogram prepared from the sequence alignments. was shown in the part of the S1 gene that was examined to have 99% identity with virus D274, a serotype of IBV first isolated in the Netherlands (Davelaar et al., 1984; Cavanagh et al., 1992) .

From 1997 the selected part of the S1 gene an identity between 86 and 94% to X (Figure 1 ). To confirm the results the S1 gene phylogeny, an N gene phylogenetic tree was also prepared (not shown). The N gene phylogenetic tree confirmed the genome identity between the SE/1096/97, SE/ 1097/97, SE/1120/97 and SE/50/98 samples and vaccine strain X (Kusters et al., 1989; Williams et al., 1992) .

The results of the diagnostic RT-PCR confirmed the highly conserved nature of the selected region of the N gene. Although already the first run of RT-PCR gave positive results with each sample and virus strain, we always applied a second run of amplification in a nested PCR, in order to provide the possible highest sensitivity of virus detection. A high number experiments has proven that, compared with single-run PCR, nested PCR assays are more sensitive (Belák & Ballagi-Pordány, 1991; Ballagi-Pordány et al., 1992) . Thus, we believe that this higher sensitivity is required for a safe diagnosis. On account of the broad reactivity of the primers chosen by the set of 14 nucleocapsid gene 232 A. Farsang et al. sequences available in GenBank, the developed PCR assay can be recommended for the general detection and identification of IBV variants in the field. The nested assay provides a powerful, novel tool in IB detection. One can argue that the highly sensitive nested PCR may yield false-positive results, and thus not be suitable for routine diagnosis. However, using all the precautions and safety arrangements of our routine diagnostic PCR laboratory (Belák & Ballagi-Pordány, 1993) , carryovers and cross-contaminations are practically eliminated and false-positive results are avoided. If necessary, the elimination of false-negative results is also possible by applying internal controls, like mimics, used in our other routine diagnostic PCR assays (Ballagi-Pordány & Belák, 1996) .

To develop a PCR assay for the phylogenetic study and to obtain results comparable with those of other authors, we have selected the first 59 part of the S1 gene for amplification. The RT-PCR system of the S1 gene proved to be suitable for determining phylogenetic relationships of the field samples (Saif, 1993; Sapats et al., 1996) except for two viruses, SE/ 242/95 and SE/340/94. The reasons why our 'phylogeny' RT-PCR assay failed to amplify these two viruses might either be an insufficient amount of the RNA or some mismatches might have been in the S1 gene of these viruses, compared with the sequences of the 'phylogeny' primers.

Similarly to the 'diagnostic' RT-PCR, no difference was revealed by 'phylogeny' RT-PCR in the results using RNA from the two different sources (trachea and intestine). For this reason, the further analysis was based entirely on the viral RNA obtained from the trachea samples. The present study revealed that viruses belonging to the Massachusetts serotype and a Dutch serotype caused natural cases in Sweden in the period 1994 to 1998. On most of the farms, Massachusetts-related strains were detected, but in one case the virus was 99% identical to strain D274. It is interesting that the D274-related strain (SE /722/95 ) was isolated in a farm situated not far (approximately 5 km) from another farm where a Massachusettsrelated virus (SE /748/95 ) was detected about 2 months earlier. This means that various variants of the virus were circulating simultaneously and independently from each other in this small geographic region. The possible origin of virus SE/ 722/95 is unclear. It can be a wild-type relative of D274. However, since D274 virus was also used as a live vaccine, it cannot be excluded that virus SE/722/95 is a D274 vaccine derivative, imported into the country. However, considering the slight genetic differences and the lack of further data, these questions remain unanswered.

The further nine viruses showed a very interesting genetic divergence. The viruses detected in the early cases (before 1997) showed genetic patterns close to strains of the Massachusetts serotype. However, complete identity was not found in comparison with any of the tested strains Genetic diversity and detection of IBV 233 of this serotype. Obviously, these might represent natural cases of IB. The close genetic relationship to the Massachusetts serotype raises some questions again that vaccinated chickens were probably purchased from some broiler company abroad where a vaccine based on a Massachusetts strain was used. Considering, that no vaccination was practised in Sweden before 1997, one can speculate that such viruses may originate only from abroad. However, it is probable that the observed viruses are not of vaccine origin, but are natural cases of IB.

Surprisingly, after introduction of IB immunization in 1997, all detected viruses showed very strong genetic relatedness to the vaccine strain. By S1 sequence analysis, four viruses showed total identity and three further ones showed identity of between 86 and 94% to the strain used in the live attenuated vaccine. All these viruses were detected in unvaccinated flocks with production problems. One can consider three main possibilities: (i) natural cases again, the causative virus being closely related or identical to the vaccine strain with regard to S1 sequence; (ii) natural superinfection happened, the vaccine virus and the field virus of another serotype both being present, and only the Massachusetts-type vaccine strain being detected by the RT-PCR; and (iii) the vaccine strain was spreading to the unvaccinated flocks and caused the observed production problems.

Considering that the genetic variability of the S1 region is very high, the first scenario seems to be very unlikely. IBV can cause persistent infections, so the type of co-existence in possibility (ii) could happen (Capua et al., 1999) . Having no previous data about the causative virus, the 'phylogeny' primers were chosen to work on a broad set of IBV genotypes, not only the Massachusetts type strains. It seems to be unlikely that some other genotype of IBV could have escaped detection. These findings are supported by the ELISA results because, after turning positive, no rising titres were revealed that would have also indicated the fact of superinfection. However, the obtained data emphasize very strongly the third scenario, the spread of the vaccine virus. The nucleotide sequences of the viruses SE/1097/97, SE/1096/97, SE/1120/97 and SE/50/98 and the vaccine strain were totally identical in a stretch of 840 S1 nucleotides, strong evidence that the five viruses are identical. One could still argue against this identity, considering that recombination is a characteristic feature of IBV (Jia et al., 1995; Kottier et al., 1995; Wang et al., 1997; Lee & Jackwood, 2000) . It may be that a virus obtains a block of heterologous sequences from another strain in its S1 region and that this can disturb the exact classification of the serotypes and/or the strains (Jia et al., 1995) . This could be an explanation; that the four viruses have another origin, but not vaccinal. However, if so, why did the four viruses 'pick up' exactly the same 840 nucleotide sequen-ces of the vaccine strain? In addition, what is the origin of these sequences, if not the vaccine itself?

Considering that the variability of S1 is very high not only for the recombinative events, but also for point mutations, insertions and also deletions, one can assume, if the entire 840 nucleotide long segment of S1 between the field viruses and a vaccine is identical, that the vaccine origin of the field viruses is the most probable explanation.

A further question is how should we consider the three further viruses (SE /1106/97, SE/422/97 and SE/423/97), which are not totally identical to the vaccine strain, but closely related in S1? One explanation is that these are also originating from the vaccine strain, but during passage in the field point mutations were accumulated in their S1 gene.

To avoid erroneous conclusions with regard to phylogeny, it is recommended to analyse the phylogenetic relations on more than one gene (Zwaagstra et al., 1992) . Therefore, phylogenetic studies were also performed in the N gene of IBV. These observations unequivocally confirmed the S1 phylogeny, indicating the vaccine origin of the discussed viruses.

In summary, sensitive novel approaches are presented here: (i) to detect rapidly all possible variants of IBV that can be warranted by the broad reactivity of the primers used in this study; and (ii) to identify genetic variants and to determine phylogeny. The N and S gene RT-PCRs may also be useful for detecting coronaviruses in other avian species; turkeys and pheasants are naturally infected by coronaviruses that are genetically very similar to IBVs (Breslin et al., 1999a,b; Guy, 2000; Cavanagh, 2001a,b; Cavanagh et al., 2001 Cavanagh et al., , 2002 . Our study has revealed very strong evidence for the spread of a live virus vaccine strain in large populations of poultry (causing damage) and a confusing epizootiological situation. These findings should be considered during the practical work to combat IB in poultry populations. Dans le but d'améliorer la détection et l'identification moléculaire du virus de la bronchite infectieuse (IBV, coronavirose aviaire), deux tests de transcription inverse et d'amplification en chaõ ne par polymérase ont eté développés (RT-PCR). Pour les études diagnostiques par PCR, un jeu de sondes nichées a été sélectionné à partir de zone hautement conservée du gène de la nucléocapside (N). Pour les études de phylogènie par PCR, un fragment du gène de la protéine de la spicule (S1) a été amplifié et les produits PCR ont été directement séquencés. Dans le but d'étudier les relations phylogénétiques des virus de différents cas, des études d'épidémiologie moléculaire ont été réalisées en Suède, une région nordique où l'apparition de cas spontanés de maladie est relativement faible et l'utilisation occasionnelle de vaccin(s) vivant(s) est bien suivie.

La maladie est apparue dans la région en 1994, associée à des problèmes de production chez les pondeuses d'âges différents. Lors des cas enregistrés entre 1995 et 1997, les pondeuses et poulets de chair ont eté affectés. Dans le but de réduire les pertes, un vaccin vivant atténué a été utilisé, à partir de 1997. L'examen en épizootiologie moléculaire de 12 virus isolés entre 1994 et 1998 révèle qu'avant 1997 les virus présentaient des séquences très similaires à celles des souches de sérotype Massachusetts. Cependant, l'analyse comparative des séquences du gène S1 a révélé que l'identité n'était pas de 100% pour toutes les souches de ce sérotype que nous avons analysées. Un virus proche de la souche hollandaise D274 a également été identifié dans uń elevage. De façon surprenante, à partir de 1997, année du début de la vaccination avec un vaccin vivant de sérotype Massachusetts, la majorité des virus isolés ont présenté des séquences de S1 identiques à la souche vaccinale vivante Massachusetts. Cette relation génétique à un virus vaccinal a également été confirmée par l'analyse de la séquence du gène N. Les études d'épizootiologie moléculaire révèlent une forte probabilité que la vaccination a permis la diffusion d'un virus vaccinal, causant différentes manifestations de maladie et brouillant la situation épizootiologique de la population avicole.

Um den Nachweis und die molekulare Identifizierung von Bronchitisvirus (IBV, aviäres Coronavirus) zu verbessern, wurden zwei Reverse-Transkriptase-Polymerase-Kettenreaktion (RT-PCR)-Tests entwickelt. Für eine "diagnostische PCR" wurde ein Set von verschachtelten Primern aus hoch konservierten Abschnitten des Nukleokapsid (N)-Gens ausgewählt. Für eine "Phylogenese"-PCR wurde ein Fragment des Spikeprotein-Gens (S1) amplifiziert und die PCR-Produkte wurden unmittelbar sequenziert. Um die phylogenetischen Beziehungen der Virusstämme von verschiedenen Ausbrüchen zu untersuchen, wurden Untersuchungen der molekularen Epizootiologie in Schweden, einer nordischen Region, durchgeführt, wo das Vorkommen von natürlichen Fällen der Krankheit relativ selten ist und die gelegentliche Verwendung von Lebendvakzine(n) gut dokumentiert und überwacht wird.

Die Krankheit tauchte 1994 in der Region auf und war mit Produktionsproblemen unter den Legehennen verschiedener Altersgruppen verbunden. Während der Ausbrüche in den Jahren 1995 und 1997 waren sowohl Legehennen als auch Broiler erkrankt. Um die Verluste zu reduzieren, wird seit 1997 eine attenuierte Lebendvakzine eingesetzt. Bei der Untersuchung von 12 Fällen zwischen 1994 und 1998 zeigte die molekulare Epizootiologie, dass die Viren vor 1997 Gen-Sequenzen hatten, die denen von Stämmen des Serotyps Massachusetts sehr ähnlich waren. Die vergleichende Sequenzanalyse des S1-Gens zeigte jedoch, dass die Identität mit keinem der von uns analysierten Stämme dieses Serotyps 100% betrug. Auch ein mit dem holländischen Referenzstamm D274 verwandtes Virus wurde auf einer Farm identifiziert. Seit 1997, dem Jahr, in dem die Impfung mit einer Lebendvakzine vom Serotyp Massachusetts begann, hatte überraschenderweise die Mehrzahl der nachgewiesenen Viren S1-Sequenzen, die mit der des Massachusetts-Vakzinestammes identisch waren. Diese genetische Beziehung zu dem Vakzinevirus wurde außerdem durch die N-Gen-Sequenzanalyse bestätigt. Die Untersuchungen der molekularen Epizootiologie offenbaren eine hohe Wahrscheinlichkeit dafür, dass die Vakzinierung zu einer Ausbreitung des Impfvirus geführt hatte, wodurch verschiedene Krankheitsmanifestationen und eine verwirrende epizootiologische Situation in der Geflügelpopulation verursacht wurden.

Con el fin de mejorar la detección y la identificación molecular de virus de bronquitis infecciosa aviar (IBV, coronavirus aviar), se desarrollaron dos métodos de transcriptasa reversa-reacción en cadena de la polimerasa (RT-PCR). Como "PCR de diagnóstico" se desarrollaron un grupo de cebadores anidados consensuados a partir de secuencias muy conservadas del gen de la nucleocápside (N). Como PCR de "filogenia", se amplificó un fragmento del gen de la proteṍ na spike (S1) y los productos de PCR se secuenciaron directamente. Con el fin de estudiar las relaciones filogenéticas de los virus de varios brotes epidémicos, se realizaron estudios de epizootiologṍ a molecular en Suecia, una región nórdica, donde hay un bajo nivel de casos naturales de esta enfermedad y donde el uso de vacuna(s) está bien controlado y monitorizado.

La enfermedad apareció en la región en 1994, asociada a problemas de producción en ponedoras de diferentes edades. Durante las epidemias de 1995 y 1997, se vieron afectados tanto los pollos de engorde como las gallinas ponedoras. Para reducir las pérdidas, se ha administrado una vacuna viva atenuada desde 1997. Mediante el examen de 12 casos entre 1994 y 1998, la epizootiologṍ a molecular reveló que antes de 1997 los virus tenṍ an secuencias génicas muy similares a las cepas del serotipo Massachusetts. Pero, al analizar comparativamente las secuencias del gen S1, se observó que ninguna de las cepas de este serotipo analizada presentaba una identidad del 100%. Un virus relacionado con la cepa de tipo holandés, D274, fue identificada en una de las granjas. Sorprendentemente, desde 1997, el año en el cual empezó la vacunación con una vacuna viva del serotipo Massachusetts, la mayorṍ a de los virus detectados presentaron una secuencia de la S1 idéntica a la de la vacuna viva de la cepa Massachusetts. Esta relación genética con el virus vacunal fue también confirmada por análisis de la secuencia del gen N. Los estudios de epizootiologṍ a molecular revelaron que con bastante probabilidad la vacunación conllevó la diseminación del virus vacunal, causando varias manisfestaciones de la enfermedad y una confusa situación epizootiológica en la población avṍ cola.

The use of mimic as internal standard to avoid false negative results in diagnostic PCR

Direct detection of bovine leukemia virus infection: practical applicability of a double polymerase chain reaction

Bovine viral diarrhea virus infection: rapid diagnosis by the polymerase chain reaction

Experiences on the applicability of the polymerase chain reaction in a diagnostic laboratory

Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus

Sequence analysis of the matrix/nucleocapsid gene region of turkey coronavirus

Sequence analysis of the turkey coronavirus nucleocapsid gene and 39 untranslated region identifies the virus as a close relative of infectious bronchitis virus

Co-circulation of four types of infectious bronchitis virus (793/B, 624/I, B1648 and Massachusetts)

Coronavirus IBV: further evidence that the surface projections are associated with two glycopeptides

Coronavirus IBV: structural characterisation of spike protein

Commentary. A nomenclature for avian coronavirus isolates and the question of species status

Technical Review: innovation and discovery: the application of nucleic acid-based technology to avian virus detection and characterisation

Location of the amino acid differences in the S1 spike glycoprotein subunit of closely related serotypes of infectious bronchitis virus

Relationship between sequence variation in the S1 spike protein of infectious bronchitis virus and the extent of cross-protection in vivo

Longitudinal field studies of infectious bronchitis virus and avian pneumovirus in broilers using type-specific polymerase chain reactions

Detection of a coronavirus from turkey poults in Europe genetically related to infectious bronchitis virus of chickens

Coronaviruses from pheasants (Phasianus colchicus) are genetically closely related to coronaviruses of domestic fowl (infectious bronchitis virus) and turkeys

Occurrence and significance of infectious bronchitis virus variant strains in egg and broiler production in the Netherlands

Technical Review. Detection of infectious bronchitis virus

The early history of infectious bronchitis

Turkey coronavirus is more closely related to avian infectious bronchitis virus than to mammalian coronavirus

Detection and strain differentation of infectious bronchitis virus in tracheal tissues from experimentally infected chickens by reverse transcription-polymerase chain reaction. Comparison with an immunohistochemical technique

A novel variant of avian bronchitis virus resulting from recombination among three different strains

Identification of recent infectious bronchitis virus isolates that are serologically different from current vaccine strains

Infectious bronchitis

Identification of avian infectious bronchitis virus by direct automated cycle sequencing of the S-1 gene

Experimental evidence of recombination in coronavirus infectious bronchitis virus

Phylogeny of antigenic variants of avian coronavirus IBV

Differentiation of infectious bronchitis virus serotype using polymerase chain reaction and restriction fragment length polymorphism analysis

The molecular biology of coronaviruses

Evidence of genetic diversity generated by recombination among avian coronavirus IBV

Origin and evolution of Georgia 98 (GA98), a new serotype of avian infectious bronchitis virus

Sequence analysis of nephropathogenic infectious bronchitis virus strains of the Massachusetts genotype in Beijing

A new typing method for the avian infectious bronchitis virus using polymerase chain reaction and restriction enzyme fragment length polymorphism

Epidemiology of infectious bronchitis virus in Belgian broilers: a retrospective study

An apparently new respiratory disease of chicks

Coronavirus immunogens. Veterinary Microbiology

Sequence analysis of the S1 glycoprotein of infectious bronchitis viruses: identification of a novel genotypic group in Australia

Introduction to poultry vaccines and immunity

Isolation of HIV-1 RNA from plasma: evaluation of eight different extraction methods

Development of nested PCR assays for detection of bovine respiratory syncytial virus in clinical samples

Evolutionary implications of genetic variations in the S1 gene of infectious bronchitis virus

Experimental confirmation of recombination upstream of the S1 hypervariable region of infectious bronchitis virus

Comparative analyses of the nucleocapsid genes of several of infectious bronchitis virus and other coronaviruses

Rapid detection and identification of avian infectious bronchitis virus

This work was supported by the Swedish Farmer's Foundation for Agricultural Research (Stiftelsen Lantbruksforskning, SLF; project number 59482). The authors would like to thank Dr Dave Cavanagh for providing NL/D1466/78, NL/H120/55, UK/ 7/91, UK/918/68, BE/B1648/84, and NL/D207/78 strains. We are grateful for the excellent technical assistance of Karin Ullman.